No increase in risk of cancer with ARB blood pressure drugs.
Angiotensin Receptor Blockers (ARBs): Drug Safety Communication - Drug Safety Review Completed
July 15th, 2010 · No Comments
Tags: FDA · FDA Alerts
No increase in risk of cancer with ARB blood pressure drugs.
Tags: FDA · FDA Alerts
0 responses so far ↓
There are no comments yet...Kick things off by filling out the form below.
You must log in to post a comment.